Historical Valuation
Beauty Health Co (SKIN) is now in the Undervalued zone, suggesting that its current forward PS ratio of 0.60 is considered Undervalued compared with the five-year average of 47.88. The fair price of Beauty Health Co (SKIN) is between 50.63 to 51.23 according to relative valuation methord. Compared to the current price of 1.46 USD , Beauty Health Co is Undervalued By 97.12%.
Relative Value
Fair Zone
50.63-51.23
Current Price：1.46
97.12%
Undervalued
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
Beauty Health Co (SKIN) has a current Price-to-Book (P/B) ratio of 2.71. Compared to its 3-year average P/B ratio of 5.10 , the current P/B ratio is approximately -46.78% higher. Relative to its 5-year average P/B ratio of 11.89, the current P/B ratio is about -77.17% higher. Beauty Health Co (SKIN) has a Forward Free Cash Flow (FCF) yield of approximately 21.58%. Compared to its 3-year average FCF yield of 2.92%, the current FCF yield is approximately 637.97% lower. Relative to its 5-year average FCF yield of 0.72% , the current FCF yield is about 2909.37% lower.
P/B
Median3y
5.10
Median5y
11.89
FCF Yield
Median3y
2.92
Median5y
0.72
Competitors Valuation Multiple
AI Analysis for SKIN
The average P/S ratio for SKIN competitors is 88.01, providing a benchmark for relative valuation. Beauty Health Co Corp (SKIN.O) exhibits a P/S ratio of 0.60, which is -99.32% above the industry average. Given its robust revenue growth of -10.34%, this premium appears unsustainable.
Performance Decomposition
AI Analysis for SKIN
1Y
3Y
5Y
Market capitalization of SKIN increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of SKIN in the past 1 year is driven by Unknown.
People Also Watch
Frequently Asked Questions
Is SKIN currently overvalued or undervalued?
Beauty Health Co (SKIN) is now in the Undervalued zone, suggesting that its current forward PS ratio of 0.60 is considered Undervalued compared with the five-year average of 47.88. The fair price of Beauty Health Co (SKIN) is between 50.63 to 51.23 according to relative valuation methord. Compared to the current price of 1.46 USD , Beauty Health Co is Undervalued By 97.12% .
What is Beauty Health Co (SKIN) fair value?
SKIN's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of Beauty Health Co (SKIN) is between 50.63 to 51.23 according to relative valuation methord.
How does SKIN's valuation metrics compare to the industry average?
The average P/S ratio for SKIN's competitors is 88.01, providing a benchmark for relative valuation. Beauty Health Co Corp (SKIN) exhibits a P/S ratio of 0.60, which is -99.32% above the industry average. Given its robust revenue growth of -10.34%, this premium appears unsustainable.
What is the current P/B ratio for Beauty Health Co (SKIN) as of Jan 10 2026?
As of Jan 10 2026, Beauty Health Co (SKIN) has a P/B ratio of 2.71. This indicates that the market values SKIN at 2.71 times its book value.
What is the current FCF Yield for Beauty Health Co (SKIN) as of Jan 10 2026?
As of Jan 10 2026, Beauty Health Co (SKIN) has a FCF Yield of 21.58%. This means that for every dollar of Beauty Health Co’s market capitalization, the company generates 21.58 cents in free cash flow.
What is the current Forward P/E ratio for Beauty Health Co (SKIN) as of Jan 10 2026?
As of Jan 10 2026, Beauty Health Co (SKIN) has a Forward P/E ratio of 9.18. This means the market is willing to pay $9.18 for every dollar of Beauty Health Co’s expected earnings over the next 12 months.
What is the current Forward P/S ratio for Beauty Health Co (SKIN) as of Jan 10 2026?
As of Jan 10 2026, Beauty Health Co (SKIN) has a Forward P/S ratio of 0.60. This means the market is valuing SKIN at $0.60 for every dollar of expected revenue over the next 12 months.